BioCentury | Aug 21, 2020
Product Development

Infectious disease society guidelines start clarifying use cases for COVID-19 serology

...the performance of the individual tests it evaluated.Guideline co-author Angela Caliendo, a professor of medicine at Brown...
BioCentury | Jul 31, 2020
Distillery Therapeutics

ADORA2B agonism for obesity and aging-induced sarcopenia

...INDICATION: Obesity; musculoskeletal Promoting adenosine signaling through ADORA2B could treat obesity and aging-induced sarcopenia. In brown...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...while partnering in ex-U.S. territories, for example. Amylyx started the company based on research at Brown...
BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...venture round in March, also hired Michael Lotze as chief cellular therapy officer and Robert Brown...
...chair of research in the department of surgery at the University of Pittsburgh Medical Center. Brown...
BioCentury | Apr 11, 2020
Translation in Brief

ILIAS Biologics’ exosomes for sepsis; plus regulating cocaine seeking and a new COVID-19 target

...announced plans to launch a discovery platform for SARS-CoV-2 inhibitors, as well as collaborate with Brown...
...B cells inhibitor α TMPRSS2 - Transmembrane protease serine 2 Daniella Kopke, Staff Writer Danielle Kopke, Staff Writer Brown...
BioCentury | Mar 13, 2020
Tools & Techniques

How to feed the machine: lessons from an AI antibiotics study

...of Collins, Regina Barzilay and Eric Brown, respectively. Barzilay is a professor at MIT, and Brown...
BioCentury | Nov 5, 2019
Company News

Green Valley’s Alzheimer’s drug targeting gut-brain-axis gets Chinese approval

...is the first drug approved worldwide since 2003 for AD. It plans to launch the brown...
BioCentury | Oct 31, 2019
Politics & Policy

FDA’s Project Facilitate fielded 161 compassionate use requests in first three months

Project Facilitate, an FDA call center that guides physicians through the process of obtaining expanded access -- or compassionate use -- to investigational cancer therapies, handled about 161 requests from its launch on June 3...
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...He was COO at Compass Therapeutics LLC. Precision cancer therapy play Syapse Inc. said Thomas Brown...
BioCentury | Oct 16, 2019
Company News

AI play Healx raises $56M to repurpose drugs for rare disease

...or that work via similar mechanisms; and predict efficacious drug combinations. Co-founder and Chairman David Brown...
...algorithm give us the initial list of hits to take human bias out of it,” Brown...
...the clinic because those discovering them biased their search on the wrong target or pathway. Brown...
Items per page:
1 - 10 of 1346
BioCentury | Aug 21, 2020
Product Development

Infectious disease society guidelines start clarifying use cases for COVID-19 serology

...the performance of the individual tests it evaluated.Guideline co-author Angela Caliendo, a professor of medicine at Brown...
BioCentury | Jul 31, 2020
Distillery Therapeutics

ADORA2B agonism for obesity and aging-induced sarcopenia

...INDICATION: Obesity; musculoskeletal Promoting adenosine signaling through ADORA2B could treat obesity and aging-induced sarcopenia. In brown...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...while partnering in ex-U.S. territories, for example. Amylyx started the company based on research at Brown...
BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...venture round in March, also hired Michael Lotze as chief cellular therapy officer and Robert Brown...
...chair of research in the department of surgery at the University of Pittsburgh Medical Center. Brown...
BioCentury | Apr 11, 2020
Translation in Brief

ILIAS Biologics’ exosomes for sepsis; plus regulating cocaine seeking and a new COVID-19 target

...announced plans to launch a discovery platform for SARS-CoV-2 inhibitors, as well as collaborate with Brown...
...B cells inhibitor α TMPRSS2 - Transmembrane protease serine 2 Daniella Kopke, Staff Writer Danielle Kopke, Staff Writer Brown...
BioCentury | Mar 13, 2020
Tools & Techniques

How to feed the machine: lessons from an AI antibiotics study

...of Collins, Regina Barzilay and Eric Brown, respectively. Barzilay is a professor at MIT, and Brown...
BioCentury | Nov 5, 2019
Company News

Green Valley’s Alzheimer’s drug targeting gut-brain-axis gets Chinese approval

...is the first drug approved worldwide since 2003 for AD. It plans to launch the brown...
BioCentury | Oct 31, 2019
Politics & Policy

FDA’s Project Facilitate fielded 161 compassionate use requests in first three months

Project Facilitate, an FDA call center that guides physicians through the process of obtaining expanded access -- or compassionate use -- to investigational cancer therapies, handled about 161 requests from its launch on June 3...
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

...He was COO at Compass Therapeutics LLC. Precision cancer therapy play Syapse Inc. said Thomas Brown...
BioCentury | Oct 16, 2019
Company News

AI play Healx raises $56M to repurpose drugs for rare disease

...or that work via similar mechanisms; and predict efficacious drug combinations. Co-founder and Chairman David Brown...
...algorithm give us the initial list of hits to take human bias out of it,” Brown...
...the clinic because those discovering them biased their search on the wrong target or pathway. Brown...
Items per page:
1 - 10 of 1346